Dissimilar distribution of Trypanosoma cruzi clones in humans after chemotherapy with allopurinol and itraconazole

Journal of Antimicrobial Chemotherapy

Volumn 58, Issue 1, 2006, Pages 216-219

  Coronado, Ximena ^a   Zulantay, Inés ^a   Rozas, Marlene ^a   Apt, Werner ^a   Sánchez, Gittith ^a   Rodríguez, Jorge ^a   Ortiz, Sylvia ^a   Solari, Aldo ^a  

^a UNIVERSITY OF CHILE   (Chile)

Author keywords

Chagas' disease; Protozoa; T. cruzi

Indexed keywords

ALLOPURINOL; ITRACONAZOLE; KINETOPLAST DNA;

ANTIBIOTIC RESISTANCE; ARTICLE; BLOOD SAMPLING; CHEMOTHERAPY; CLONE; CONTROLLED STUDY; DRUG SENSITIVITY; DRUG TREATMENT FAILURE; GENOTYPE; HUMAN; NONHUMAN; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; SOUTHERN BLOTTING; TRIATOMA INFESTANS; TRYPANOSOMA CRUZI; TRYPANOSOMIASIS;

ALLOPURINOL; ANIMALS; ANTIPROTOZOAL AGENTS; CHAGAS DISEASE; HUMANS; ITRACONAZOLE; TRYPANOSOMA CRUZI;

EID: 33748067427     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dkl192     Document Type: Article

References (21)

1. World Health Organization. Control of Chagas Disease: Second Report of the WHO Expert Committee. Technical Reports Series. Geneva: WHO, 2002.
2. Tibayrenc M. Genetic subdivisions within Trypanosoma cruzi (Discrete Typing Units) and their relevance for molecular epidemiology and experimental evolution. Kinetoplastid Biol Dis 2003; 2: 12.
3. Andrade SG, Magalhães JB, Pontes AL. Evaluation of chemotherapy with benznidazole and nifurtimox in mice infected with Trypanosoma cruzi strains of different types. Bull World Health Organ 1985; 63: 721-6.
4. Filardi LS, Brener Z. Susceptibility and natural resistance to Trypanosoma cruzi strains to drugs used clinically in Chagas disease. Trans R Soc Trop Med Hyg 1987; 81: 755-9.
5. Cançado JR. Criteria of Chagas disease cure. Mem Inst Oswaldo Cruz 1999; 94 Suppl 1: 331-6.
6. Andrade SG, Rassi A, Magalhães JB et al. Specific chemotherapy of Chagas disease: A comparison between the response in patients and experimental animals inoculated with the same strains. Trans R Soc Trop Med Hyg 1992; 86: 624-6.
7. Camandaroba ELP, Reis EAG, Gonçalves MS et al. Trypanosoma cruzi: susceptibility to chemotherapy with benznidazole of clones isolated from the highly resistant Colombian strain. Rev Soc Bras Med Trop 2003; 36: 201-9.
8. Sosa Estani S, Segura EL. Treatment of Trypanosoma cruzi infection in the undetermined phase. Experience and current guidelines of treatment in Argentina. Mem Inst Oswaldo Cruz 1999; 94 Suppl 1: 363-5.
9. Andrade AL, Martelli CM, Oliveira RM et al. Short report: Benznidazole efficacy among Trypanosoma cruzi-infected adolescents after a six-year follow-up. Am J Trop Med Hyg 2004; 71: 594-7.
10. Solari A, Ortiz S, Soto A et al. Treatment of Trypanosoma cruzi-infected children with nifurtimox: A 3 year follow-up by PCR. J Antimicrob Chemother 2001; 48: 515-9.
11. Rodrígues Coura J, de Castro SL. A critical review on Chagas disease chemotherapy. Mem Inst Oswaldo Cruz 2002; 97: 3-24.
12. Lauria-Pires L, Braga MS, Vexenat AC et al. Progressive chronic Chagas heart disease ten years after treatment with anti-Trypanosoma cruzi nitroderivatives. Am J Trop Med Hyg 2000; 63: 111-8.
13. Urbina JA. Specific treatment of Chagas disease: Current status and new developments. Curr Opin Infect Dis 2001; 14: 733-41.
14. Gallerano RH, Marr JJ, Sosa RR. Therapeutic efficacy of allopurinol in patients with chronic Chagas' disease. Am J Trop Med Hyg 1990; 43: 159-66.
15. Buckner F, Yokohama K, Lockman J et al. A class of sterol 14-demethylase inhibitors as anti- Trypanosoma cruzi agents. Proc Natl Acad Sci USA 2003; 100: 15149-53.
16. Apt W, Aguilera X, Arribada A et al. Treatment of chronic Chagas' disease with itraconazole and allopurinol. Am J Trop Med Hyg 1998; 59: 133-8.
17. Apt W, Arribada A, Zulantay I et al. Itraconazole or allopurinol in the treatment of chronic American trypanosomiasis: The results of clinical and parasitological examinations 11 years post-treatment. Ann Trop Med Parasitol 2005; 99: 733-41.
18. Schenone H. Xenodiagnosis. Mem Inst Oswaldo Cruz 1999; 94: 289-94.
19. Torres JP, Ortiz S, Muñoz S et al. Trypanosoma cruzi isolates from Chile are heterogeneous and composed of mixed populations when characterized by schizodeme and Southern analyses. Parasitology 2004; 128: 161-8.
20. Coronado X, Zulantay I, Albrecht H et al. Variation in Trypanosoma cruzi clonal composition detected in blood patients and xenodiagnosis triatomines: Implications in the molecular epidemiology of Chile. Am J Trop Med Hyg 2006; in press.
21. Omelas Toledo MJ, Bahia MT, Cameiro CM et al. Chemotherapy with benznidazole and itraconazole for mice infected with different Trypanosoma cruzi clonal genotypes. Antimicrob Agents Chemother 2003; 47: 223-30.